Tuesday, March 24, 2020 5:46:30 PM
Shares of Onconova Therapeutics, Inc. are trading higher in Tuesday's after-hours market, after the company said it completed enrolling patients in a Phase 3 trial and reported higher net revenue for 2019 over the previous year.
At 5:07 p.m. EDT, Onconova shares had risen 17.78% to trade at 43 cents. Volume in the after-hours session topped 3.7 million shares.
The company's stock finished the day's regular-trading session with a 15.58% gain, closing at 36 cents.
Onconova said it had completed enrolling 360 patients in the Phase 3 Inspire trial, which is designed to test the efficacy and safety of IV rigosertib in certain patients suffering from myelodysplastic syndromes, a type of cancer that can disrupt the production of blood cells.
Steven M. Fruchtman, the company's president and chief executive, said, "We are also pleased about the progress of our plans for additional investigator-initiated studies - including the Phase 1/2a study of rigosertib plus nivolumab for the treatment of Stage IV KRAS mutated lung adenocarcinoma. We anticipate the first patient to be entered onto the trial once the COVID-19 environment improves sufficiently."
The company reported 2019 revenue of $2,183,000, above the 2018 figure of $1,228,000.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
March 24, 2020 17:32 ET (21:32 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Recent ONTX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 10:38:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 10:36:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/08/2024 09:09:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/27/2023 08:41:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/27/2023 08:35:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 09:00:13 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM